Newsletter | August 29, 2025

08.29.25 -- Unlocking The Potential Of iPSC Therapies In Regenerative Medicine

SPONSOR

Webinar: Advances in Pediatric Transplant: T-cell Depleted Haploidentical Experience

Join Miltenyi Biotec for an insightful live webinar on transforming pediatric transplant care with T cell–depleted haploidentical HSCT. Learn how this cutting-edge approach expands donor access while minimizing GVHD risk. Hear firsthand clinical experiences, explore immune recovery data, and discover how virus-specific T cells may shape the future of transplantation. Don’t miss this opportunity to deepen your expertise—register now! Click here to learn more.

FOCUS ON CLINICAL TRIALS

Unlocking The Potential Of iPSC Therapies In Regenerative Medicine

In a recent Cell & Gene Live, leaders from Mayo Clinic and Astellas discussed the transformative potential of iPSC therapies in regenerative medicine, highlighting regulatory alignment and manufacturing innovation to realize their full impact.

Critical Imaging Risks In GLP-1 And Neurology Studies

As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that supports participant safety and reproducible outcomes.

Revolutionizing Clinical Analytics

In this 4-part series, learn about AI-driven methods that streamline data mapping and highlight critical issues that allow clinical teams to focus on what truly matters.

Enhance Access And Improve Retention In Rare Disease Trials With HTS

Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.

Global Start-Up For Multinational Geographic Atrophy Trial

This partnership allowed a leading biopharmaceutical company to navigate the complexities of a Phase IIb study investigating a novel pegylated RNA adapter for geographic atrophy secondary to dry AMD.

CLINICAL TRIALS SOLUTIONS

Clinical Pharmacokinetics And Pharmacometrics - CHDR

Accelerating Trial Enrollment With Data-Driven Outreach - Quest Diagnostics

FOCUS ON SUPPLY CHAIN

Why 'Which Is Best?' Is The Wrong Question In CGT Development

In cell therapy development, the instinct to seek a single “best” option is natural — but in reality, there’s rarely a universal winner.

4 Ways To Safeguard Your Supply Of Fetal Bovine Serum

A fetal bovine serum shortage would have significant repercussions throughout the life sciences industry. However, there are a few steps FBS users can take now to secure their supply chain.

Polymer Technology Takes Freeze Containers Beyond The Breaking Point

Learn about new materials being considered for single-use cold chain storage containers to reduce or eliminate issues with durability at cold temperatures.

Connect With Cell & Gene: